Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
3.240
+0.640 (24.62%)
At close: Oct 23, 2026, 4:00 PM EDT
3.260
+0.020 (0.62%)
After-hours: Oct 23, 2026, 7:59 PM EDT
Nautilus Biotechnology Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Nautilus Biotechnology stock has a consensus rating of "Strong Buy" and an average price target of $3.83. The average 1-year stock price forecast is 18.21% higher than the current stock price, while the lowest is $3.50 (+8.02%) and the highest is $4.00 (+23.46%).
Price Target: $3.83 (+18.21%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Nautilus Biotechnology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | Jul '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Buy Initiates $3.5 | Buy | Initiates | $3.5 | +8.02% | Sep 29, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Initiates $4 | Buy | Initiates | $4 | +23.46% | Sep 9, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $4 | Buy | Reiterates | $4 | +23.46% | Jul 29, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Apr 28, 2026 |
Financial Forecast
Revenue This Year
536.25K
Revenue Next Year
5.16M
from 536.25K
Increased by 862.33%
EPS This Year
-0.61
EPS Next Year
-0.60
from -0.61
EPS and Forward PE are based on non-GAAP adjusted numbers.